Suppr超能文献

糖和人工甜味饮料与肥胖、2 型糖尿病、高血压和全因死亡率的关系:前瞻性队列研究的剂量反应荟萃分析。

Sugar and artificially sweetened beverages and risk of obesity, type 2 diabetes mellitus, hypertension, and all-cause mortality: a dose-response meta-analysis of prospective cohort studies.

机构信息

Department of Biostatistics and Epidemiology, School of Public Health, Shenzhen University Health Science Center, No. 1066 Xueyuan Avenue, Nanshan District, Shenzhen, 518060, Guangdong, People's Republic of China.

The Affiliated Luohu Hospital of Shenzhen University Health Science Center, Shenzhen, Guangdong, People's Republic of China.

出版信息

Eur J Epidemiol. 2020 Jul;35(7):655-671. doi: 10.1007/s10654-020-00655-y. Epub 2020 Jun 11.

Abstract

Although consumption of sugar-sweetened beverages (SSBs) and artificially sweetened beverages (ASBs) has increasingly been linked with obesity, type 2 diabetes mellitus, hypertension, and all-cause mortality, evidence remains conflicted and dose-response meta-analyses of the associations are lacking. We conducted an updated meta-analysis to synthesize the knowledge about their associations and to explore their dose-response relations. We comprehensively searched PubMed, EMBASE, Web of Science, and Open Grey up to September 2019 for prospective cohort studies investigating the associations in adults. Summary relative risks (RRs) and 95% confidence intervals (CIs) were estimated for the dose-response association. Restricted cubic splines were used to evaluate linear/non-linear relations. We included 39 articles in the meta-analysis. For each 250-mL/d increase in SSB and ASB intake, the risk increased by 12% (RR = 1.12, 95% CI 1.05-1.19, I = 67.7%) and 21% (RR = 1.21, 95% CI 1.09-1.35, I = 47.2%) for obesity, 19% (RR = 1.19, 95% CI 1.13-1.25, I = 82.4%) and 15% (RR = 1.15, 95% CI 1.05-1.26, I = 92.6%) for T2DM, 10% (RR = 1.10, 95% CI 1.06-1.14, I = 58.4%) and 8% (RR = 1.08, 95% CI 1.06-1.10, I = 24.3%) for hypertension, and 4% (RR = 1.04, 95% CI 1.01-1.07, I = 58.0%) and 6% (RR = 1.06, 95% CI 1.02-1.10, I = 80.8%) for all-cause mortality. For SSBs, restricted cubic splines showed linear associations with risk of obesity (P = 0.359), T2DM (P = 0.706), hypertension (P = 0.510) and all-cause mortality (P = 0.259). For ASBs, we found linear associations with risk of obesity (P = 0.299) and T2DM (P = 0.847) and non-linear associations with hypertension (P = 0.019) and all-cause mortality (P = 0.048). Increased consumption of SSBs and ASBs is associated with risk of obesity, T2DM, hypertension, and all-cause mortality. However, the results should be interpreted cautiously because the present analyses were based on only cohort but not intervention studies.

摘要

尽管越来越多的证据表明,饮用含糖饮料(SSB)和人工甜味饮料(ASB)与肥胖、2 型糖尿病、高血压和全因死亡率有关,但证据仍然存在冲突,并且缺乏对这些关联的剂量反应荟萃分析。我们进行了一项更新的荟萃分析,以综合了解这些关联,并探讨它们的剂量反应关系。我们全面搜索了 PubMed、EMBASE、Web of Science 和 Open Grey 数据库,以获取截至 2019 年 9 月的前瞻性队列研究,以调查成年人中这些关联。为了评估剂量反应关联,我们估计了每个 250 毫升/天 SSB 和 ASB 摄入量的综合相对风险(RR)和 95%置信区间(CI)。限制立方样条用于评估线性/非线性关系。我们将 39 篇文章纳入荟萃分析。对于 SSB 和 ASB 摄入量每增加 250 毫升/天,肥胖的风险分别增加 12%(RR=1.12,95%CI 1.05-1.19,I=67.7%)和 21%(RR=1.21,95%CI 1.09-1.35,I=47.2%),2 型糖尿病的风险分别增加 19%(RR=1.19,95%CI 1.13-1.25,I=82.4%)和 15%(RR=1.15,95%CI 1.05-1.26,I=92.6%),高血压的风险分别增加 10%(RR=1.10,95%CI 1.06-1.14,I=58.4%)和 8%(RR=1.08,95%CI 1.06-1.10,I=24.3%),全因死亡率的风险分别增加 4%(RR=1.04,95%CI 1.01-1.07,I=58.0%)和 6%(RR=1.06,95%CI 1.02-1.10,I=80.8%)。对于 SSB,限制立方样条显示与肥胖风险(P=0.359)、2 型糖尿病(P=0.706)、高血压(P=0.510)和全因死亡率(P=0.259)呈线性关联。对于 ASB,我们发现与肥胖风险(P=0.299)和 2 型糖尿病风险(P=0.847)呈线性关联,与高血压(P=0.019)和全因死亡率(P=0.048)呈非线性关联。增加 SSB 和 ASB 的摄入量与肥胖、2 型糖尿病、高血压和全因死亡率的风险有关。然而,由于目前的分析仅基于队列研究而不是干预研究,因此结果应谨慎解释。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验